Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Petrus Resources ltd	6P4	22. nov 2024	0.95	+1.06
Pets at Home Group Plc	6P8	22. nov 2024	3.34	+0.42
Peugeot Invest	FFP	22. nov 2024	69.90	+0.43
PEXA AB SER.B	FA0	22. nov 2024	0.02	+4.85
Pexip Holding	4W9	22. nov 2024	3.62	+2.26
Peyto Exploration & Development Corp.	PXK	22. nov 2024	11.73	+0.64
Pfeiffer Vacuum Technology AG	PFV	22. nov 2024	154.00	+0.13
Pferdewetten.de AG	EMH	22. nov 2024	4.82	-2.03
PFERDEWETTEN.DE NA NEUE	EMH0	22. nov 2024	2.50	-16.67
PFIZER INC.CDR REG.S	PFEB	22. nov 2024	7.70	+1.32
Pfizer, Inc.	PFE	22. nov 2024	24.54	+2.79
PGE Polska Grupa Energetyczna SA	6PG	22. nov 2024	1.56	+2.54
Pharmamar S.A.	PMRA	22. nov 2024	72.95	-2.01
Pharmanutra S.p.A.	761	22. nov 2024	53.50	+0.19
Pharmaron Beijing Co Ltd	17Q1	22. nov 2024	1.58	-5.39
PHARMASGP HOLDING SE O.N.	PSG	22. nov 2024	23.60	0.00
Pharmaust Ltd.	ECQ	22. nov 2024	0.13	0.00
Pharming Group N.V. - ADS, each representing 10 ordinary sha	PHG	22. nov 2024	6.90	+2.99
Pharming Group NV	PHGN	22. nov 2024	0.71	-2.28
PHarol SGPS SA	PTCA	22. nov 2024	0.04	0.00
Pharos Energy Plc	OCS1	22. nov 2024	0.25	0.00
Pharvaris N.V. - Ordinary Shares	9EN	22. nov 2024	20.60	+7.85
PHASE HOLO.IMAG.PHI SK-20	L5W	22. nov 2024	0.14	+0.35
PHAXIAM THERAPEUT. EO 1,-	2E40	22. nov 2024	1.49	-8.02
PHC Holdings Corporation	2GY	22. nov 2024	6.25	+5.93
PhenixFIN	Q29	22. nov 2024	43.60	+1.40
Phenom Resources Corp	1PY0	22. nov 2024	0.27	+8.87
Phibro Animal Health Corporation - Class A	PB8	22. nov 2024	22.40	+1.82
Phicomm AG	HBD1	22. nov 2024	0.97	0.00
Philion Se Bearer NPV	PH6	22. nov 2024	0.45	+0.91

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.